Serum levels of insulin-like growth factors (IGFs) and their binding proteins (IGFBPs), -1, -2, -3, in oral cancer

International Journal of Oral and Maxillofacial Surgery

Volumn 36, Issue 3, 2007, Pages 259-262

  Brady, G ^a   O'Regan, E ^b,c   Miller, I ^c   Ogungbowale, A ^c   Kapas, S ^d   Crean, S J ^e  

^a YORK HOSPITAL   (United Kingdom)

^b DUBLIN DENTAL UNIVERSITY HOSPITAL   (Ireland)

^c ST JAMES S HOSPITAL   (Ireland)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e PRINCE CHARLES HOSPITAL   (United Kingdom)

Author keywords

IGF; IGFBP; oral cancer

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER SIZE; CANCER SURGERY; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MOUTH CANCER; MOUTH CARCINOMA; PROTEIN BLOOD LEVEL; SQUAMOUS CELL CARCINOMA; SURGICAL PATIENT;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MOUTH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846696722     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2006.09.009     Document Type: Article

References (21)

1. Baron-Hay S., Boyle F., Ferrier A., and Scott C. Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clin Cancer Res 10 (2004) 1796-1806
2. Bhatavdekar J.M., Patel D.D., Vora H.H., and Balar D.B. Circulating markers and growth factors as prognosticators in men with advanced tongue cancer. Tumour Biol 14 (1993) 55-58
3. Chan J.M., Stampfer M.J., Giovannucci E., Gann P.H., Ma J., Wilkinson P., Hennekens C.H., and Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 (1998) 563-566
4. Dunn S.E., Kari F.W., French J., Leininger J.R., Travlos G., Wilson R., and Barrett J.C. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57 (1997) 4667-4672
5. Firth S.M., and Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23 (2002) 824-854
6. Furlanetto R.W., Harwell S.E., and Frick K.K. Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro. Mol Endocrinol 8 (1994) 510-517
7. Giovannucci E., Pollak M.N., Platz E.A., Willett W.C., Stampfer M.J., Majeed N., Colditz G.A., Speizer F.E., and Hankinson S.E. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9 (2000) 345-349
8. Hankinson S.E., Willett W.C., Colditz G.A., Hunter D.J., Michaud D.S., Deroo B., Rosner B., Speizer F.E., and Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (1998) 1393-1396
9. Miyake H., Pollak M., and Gleave M.E. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. Cancer Res 60 (2000) 3058-3064
10. Oh Y. IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth. Endocrine 7 (1997) 111-113
11. Pollak M. Insulin-like growth factors and prostate cancer. Epidemiol Rev 23 (2001) 59-66
12. Pollak M.N., Schernhammer E.S., and Hankinson S.E. Insulin-like growth factors and neoplasia. Nat Rev Cancer 4 (2004) 505-518
13. Probst-Hensch N.M., Yuan J.M., Stanczyk F.Z., Gao Y.T., Ross R.K., and Yu M.C. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 85 (2001) 1695-1699
14. Spitz M.R., Barnett M.J., Goodman G.E., Thornquist M.D., Wu X., and Pollak M. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev 11 (2002) 1413-1418
15. Stattin P., Bylund A., Rinaldi S., Biessy C., Dechaud H., Stenman U.H., Egevad L., Riboli E., Hallmans G., and Kaaks R. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92 (2000) 1910-1917
16. Tennant M.K., Thrasher J.B., Twomey P.A., Drivdahl R.H., Birnbaum R.S., and Plymate S.R. Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J Clin Endocrinol Metab 81 (1996) 3774-3782
17. Wu X., Zhao H., Do K.A., Johnson M.M., Dong Q., Hong W.K., and Spitz M.R. Serum levels of insulin growth factor (IGF-1) and IGF-binding protein predict risk of secondary primary tumours in patients with head and neck cancer. Clin Cancer Res 10 (2004) 3988-3995
18. Vasan R.S., Sullivan L.M., D'Agostino R.B., Roubenoff R., Harris T., Sawyer D.B., Levy D., and Wilson P.W. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med 139 (2003) 642-648
19. Wu X., Yu H., Amos C.I., Hong W.K., and Spitz M.R. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst 92 (2000) 737-743
20. Wu Y., Yakar S., Zhao L., Hennighausen L., and LeRoith D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res 62 (2002) 1030-1035
21. Yu H., Jin F., Shu X.O., Li B.D., Dai Q., Cheng J.R., Berkel H.J., and Zheng W. Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 11 (2002) 705-712